llumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference Call
Illumina (NASDAQ:ILMN) has announced a live webcast of the Innovation Roadmap session at the Illumina Genomics Forum, hosted by CEO Francis deSouza and CTO Alex Aravanis on September 29, 2022. The session is scheduled from 9:00-10:00 AM PT and will be followed by a conference call at 11:30 AM PT, where executives will discuss the roadmap and address inquiries. Investors can access the live webcast via the Investor Info section of Illumina's website. A replay of the call will be available for 30 days following the event.
- Live webcast offers transparency and direct communication with investors.
- Opportunity for stakeholders to engage during the conference call.
- Focus on innovation may bolster investor confidence.
- None.
SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) today announced that investors, analysts, and other interested parties may view a live webcast of the Innovation Roadmap session of the Illumina Genomics Forum, which will be hosted by Francis deSouza, Chief Executive Officer, and Alex Aravanis, Chief Technology Officer. The session will be held from 9:00-10:00am Pacific Time (12:00-1:00pm Eastern Time), Thursday, Sept. 29, 2022.
On the same day, from 11:30-12:00pm Pacific Time (2:30-3:00pm Eastern Time), Francis deSouza, Chief Executive Officer, Joydeep Goswami, Chief Strategy and Corporate Development Officer and Interim Chief Financial Officer, and Alex Aravanis, Chief Technology Officer, will host a conference call with analysts, investors, and other interested parties to discuss the Innovation Roadmap session and address questions.
Interested parties may access the live webcast of the Innovation Roadmap session of the Illumina Genomics Forum through the Investor Info section of Illumina's website at investor.illumina.com. Individuals may access the live investor conference call with Illumina management through the same page or, alternatively, by dialing 866.409.1555 or +1.313.209.4906 outside North America, both with Conference ID 7572314.
A replay of the investor conference call will be posted on Illumina's website after the event and will be available for at least 30 days following.
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and connect with us on Twitter, Facebook, LinkedIn, Instagram, and YouTube.
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Sarah Shew
+1.858.336.3157
sshew@illumina.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/llumina-announces-opportunity-to-view-live-webcast-of-illumina-genomics-forum-innovation-roadmap-session-followed-by-investor-conference-call-301619903.html
SOURCE Illumina, Inc.
FAQ
When will the Illumina Genomics Forum Innovation Roadmap session take place?
Who is hosting the Innovation Roadmap session at the Illumina Genomics Forum?
How can I access the live webcast of the Illumina Genomics Forum?
What time is the investor conference call following the Innovation Roadmap session?
Will there be a replay available for the investor conference call?
